CollPlant Biotechnologies Ltd. Reports February 2025 Insights in Form 6-K Filing

Here are the key insights and information extracted from the provided financial report section for CollPlant Biotechnologies Ltd.:

1. Filing Type and Date: This document is a Form 6-K, filed on February 12, 2025.
2. Company Information:

• Name: CollPlant Biotechnologies Ltd.
• Address: 4 Oppenheimer St, Weizmann Science Park, Rehovot 7670104, Israel.
• Commission File Number: 001-38370.

3. Report Type: The document is a report of a foreign private issuer, filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
4. Reporting Period: The report covers the month of February 2025.
5. Incorporation of Documents: The report incorporates by reference specific sections from a press release and a corporate presentation:

• Press Release: Titled "CollPlant Biotechnologies Provides a Corporate Update" (Exhibit 99.1).
• Corporate Presentation: An updated corporate presentation (Exhibit 99.2).

6. Forms Filed: The company indicated that it files annual reports under the cover of Form 20-F.
7. Signatory: The report is signed by Eran Rotem, who serves as the Deputy CEO and Chief Financial Officer.
8. Exhibits: The report includes two important attachments:

• Exhibit 99.1: Press Release dated February 12, 2025.
• Exhibit 99.2: Corporate Presentation.

This summary provides a clear overview of the essential details contained in the financial report, including the company's identity, the nature of the filing, and the incorporation of relevant documents.